EUVIMEDEUVIMED entdecken
Crossref

Impact of orthokeratology and low‐dose atropine on corneal biomechanics and myopia progression in children

Ssu-Hsien Lee iD, Ping-Chiao Tsai, Yu-Chieh Chiu, Jen-Hung Wang, Cheng-Jen Chiu iD

Ophthalmic and Physiological Optics · 2025

DOI: 10.1111/opo.13446 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ophthalmic and Physiological Optics, 2025. Verfasst von Ssu-Hsien Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Tzu Chi University, Hualien, Taiwan. Hauptthemen laut MEDLINE: Atropine, Orthokeratologic Procedures, Cornea, Myopia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study evaluated the effects of orthokeratology and 0.01% atropine on corneal biomechanical properties (CBPs) and myopia progression in children, focusing on their association with axial length (AL) changes and treatment outcomes.

Methods

In this 1‐year prospective study, 53 children (aged 8–17 years) were enrolled, with 30 undergoing orthokeratology and 23 receiving 0.01% atropine. CBP parameters, including the Corvis Biomechanical Index (CBI), central corneal thickness (CCT), biomechanically corrected intraocular pressure (bIOP) and stress–strain index (SSI), were assessed at baseline and during follow‐ups at 1, 3, 6, 9 and 12 months. The orthokeratology group was further stratified into good and poor responders based on early myopia reduction.

Results

The orthokeratology group exhibited a significant increase in CBI over time, particularly among good responders, while CCT, bIOP and SSI remained stable. In contrast, no significant changes in CBPs were observed in the atropine group. AL elongation showed no significant correlation with CBP changes in either group. The orthokeratology group achieved superior control of myopia progression compared to the atropine group at 12 months, with poor responders exhibiting better long‐term AL control.

Conclusions

Both orthokeratology and 0.01% atropine were effective in controlling myopia. While atropine had no impact on CBPs, the increase in CBI with orthokeratology may predict early treatment outcomes. However, the initial response to orthokeratology did not guarantee long‐term effectiveness, highlighting the need for individualised treatment monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtropineOrthokeratologic ProceduresCorneaMyopiaRefraction, OcularHumansChildAdolescentFemaleMaleDisease ProgressionProspective StudiesBiomechanical PhenomenaFollow-Up StudiesMydriaticsIntraocular PressureAxial Length, EyeOphthalmic SolutionsDose-Response Relationship, Drug

Stichwörter der Autor:innen

Corvis STatropinecorneal biomechanical propertiesmyopiaorthokeratology

Substanzen

AtropineMydriaticsOphthalmic Solutions

Autor:innen und Institutionen

  • School of Medicine, Tzu Chi University, Hualien, Taiwan.
  • Medical Department, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.
  • Department of Medical Research, Buddhist Tzu Chi General Hospital, Hualien, Taiwan.
  • Department of Ophthalmology and Visual Science, Tzu Chi University, Hualien, Taiwan.
  • Department of Ophthalmology, Hualien Tzu Chi Hospital, the Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.

ORCID-Profile: Ssu-Hsien Lee, Cheng-Jen Chiu

Zitieren

APA

Lee, S. H., Tsai, P. C., Chiu, Y. C., Wang, J. H., & Chiu, C. J. (2025). Impact of orthokeratology and low‐dose atropine on corneal biomechanics and myopia progression in children. Ophthalmic and Physiological Optics. https://doi.org/10.1111/opo.13446

Vancouver

Lee SH, Tsai PC, Chiu YC, Wang JH, Chiu CJ. Impact of orthokeratology and low‐dose atropine on corneal biomechanics and myopia progression in children. Ophthalmic and Physiological Optics. 2025. doi:10.1111/opo.13446

BibTeX
@article{Lee2025,
  author = {Lee, Ssu-Hsien and Tsai, Ping-Chiao and Chiu, Yu-Chieh and Wang, Jen-Hung and Chiu, Cheng-Jen},
  title = {Impact of orthokeratology and low‐dose atropine on corneal biomechanics and myopia progression in children},
  journal = {Ophthalmic and Physiological Optics},
  year = {2025},
  doi = {10.1111/opo.13446}
}
Kostenlos starten →